CYTH: cyclotherapeutics.com Expected earnings per share growth for next year

Public company logo of Cyclo Therapeutics (CYTH)

The merger with an investment holding company helps Cyclo Therapeutics (CYTH) mitigate the risks associated with its narrow specialization in genetic pathologies. The projected net profit trend confirms this trajectory, where the 0.00 metric reflects current expectations. Intellectual property protection and stringent FDA oversight create high barriers to entry, while transparent management ensures a confident dialogue with shareholders.

Cyclo Therapeutics Inc. (CYTH): Net earnings per share change forecast for next year from 07/04/2022 to 04/05/2025

Analytical breakdowns and data insights for company Cyclo Therapeutics Inc. (CYTH)

- share price and consensus valuation forecast:
Fundamental company valuation:CYTH, cyclotherapeutics.com
Finished products of Cyclo Therapeutics, Inc.

This indicator measures the expected earnings per share (EPS) dynamics, calculated as the arithmetic mean of leading analysts' forecasts for the coming year. By analyzing the forward net income trend on GURU.Markets, an investor assesses the margin stability of Cyclo Therapeutics (CYTH), which is supported by the diversification of raw material supplies for cyclodextrins, minimizing logistical risks and ensuring steady operational growth.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Arcturus Pharma|ETON: Expected earnings per share trend next year|Net earnings per share growth forecast for next year kamada.com (KMDA)|Expected earnings per share growth for next year Fulcrum Therapeutics FULC|Earnings growth forecast for next year ABEO (Abeona Therapeutics, Inc.)|Earnings growth forecast for next year Mereo BioPharma MREO|PLX - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PLRX|Applied Therapeutics (APLT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Rein Therapeutics Inc (RNTX)|Net earnings per share growth forecast for next year Gelteq Limited|AYTU (Aytu BioPharma) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Chemomab Therapeutics Ltd (CMMB)|SRXH (SRx Health Solutions) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Polyrizon Ltd PLRZ|Expected earnings per share trend next year AEZS|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year